This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignees: Guangzhou Henovcom Bioscience Co. Ltd, Guangzhou Henovcom Bioscience Co., Ltd.. Active years: 2023-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 6 
1 out of 1 Years Active: 2023-2026
Title: Qingan Zou - Innovator in Heteroaromatic Compounds
Introduction
Qingan Zou is a notable inventor based in China, recognized for his contributions to the field of pharmaceutical chemistry. His work primarily focuses on the development of heteroaromatic compounds, which have significant implications in medical treatments.
Latest Patents
Although Qingan Zou currently holds no patents, he has made significant strides in his research. His notable work includes the invention of a novel heteroaromatic compound that acts as an Autotaxin (ATX) inhibitor. This compound is part of a pharmaceutical composition aimed at treating diseases characterized by Autotaxin overexpression in mammals.
Career Highlights
Throughout his career, Qingan Zou has demonstrated a commitment to advancing pharmaceutical science. His research has the potential to impact various therapeutic areas, particularly those related to diseases linked to Autotaxin.
Collaborations
Qingan Zou has collaborated with esteemed colleagues such as Jiancun Zhang and Yanwei Chen. These partnerships have likely contributed to the depth and breadth of his research endeavors.
Conclusion
Qingan Zou's innovative work in the field of heteroaromatic compounds showcases his dedication to pharmaceutical advancements. His research holds promise for future medical applications and highlights the importance of collaboration in scientific discovery.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile